Status:
COMPLETED
Psychometric Properties of the Updated Module on Assessing Quality of Life of Patients With Breast Cancer
Lead Sponsor:
Helios University Hospital Wuppertal
Collaborating Sponsors:
Medical University of Graz
Université Catholique de Louvain
Conditions:
Breast Cancer
Quality of Life
Eligibility:
FEMALE
18+ years
Brief Summary
Females breast cancer is still the most frequent type of cancer in Europe with 21 per 100,000 women .The EORTC QLQ-BR23 was one of the first modules developed to be used in conjunction with the core q...
Eligibility Criteria
Inclusion
- histologically confirmed diagnosis of breast cancer
- no previous primary or recurrent tumour
- ability to understand the language of the questionnaire
- mental fitness to complete a questionnaire
- 18 years of age or above
- written informed consent.
Exclusion
- no histologically confirmed diagnosis of breast cancer
- previous primary or recurrent tumour
- not mentally fit to complete a questionnaire
- not able to understand the language of the questionnaire
- younger than 18
- refusal of informed consent
Key Trial Info
Start Date :
June 14 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 17 2021
Estimated Enrollment :
576 Patients enrolled
Trial Details
Trial ID
NCT04018235
Start Date
June 14 2019
End Date
December 17 2021
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helios Universitiätsklinikum Wuppertal, Universität Witten/Herdecke
Wuppertal, Germany, 42283